This company has been marked as potentially delisted and may not be actively trading. NASDAQ:MIRO Miromatrix Medical (MIRO) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Miromatrix Medical Stock (NASDAQ:MIRO) Get Miromatrix Medical alerts:Sign Up Key Stats Today's Range$3.39▼$3.3950-Day Range$3.31▼$3.4052-Week Range$0.91▼$4.35VolumeN/AAverage Volume80,095 shsMarket Capitalization$92.95 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. The company's proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells. It has collaborations with Baxter, CareDx, The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company was formerly known as TayTech, Inc. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota. Read More Receive MIRO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Miromatrix Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MIRO Stock News HeadlinesUnited Therapeutics and Intermountain Health Announce the First Patient Treated With External Liver Support Using a Bioengineered Liver - MorningstarJune 25, 2025 | morningstar.comMUniversity of Minnesota Venture Center Director Russ Straate retiresOctober 16, 2024 | bizjournals.comBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly building the infrastructure for decentralized AI and asset-backed tokens — and its latest $90M acquisition move could make it a critical player in the next financial reset.October 16 at 2:00 AM | Intellistake (Ad)BioLargo, Inc.: Clyra Medical Technologies, a Subsidiary of BioLargo, Appoints Dr. Steven J. Kavros as Chief Medical OfficerSeptember 9, 2024 | finanznachrichten.deClyra Medical Technologies Appoints Dr. Steven J. Kavros as Chief Medical OfficerSeptember 9, 2024 | finance.yahoo.comUnited Therapeutics to build $100M pig-to-human organ research center in southeast MinnesotaAugust 15, 2024 | startribune.comSQ4 2023 United Therapeutics Corp Earnings CallFebruary 22, 2024 | uk.finance.yahoo.comBest Stocks to Buy Right NowNovember 22, 2023 | benzinga.comSee More Headlines MIRO Stock Analysis - Frequently Asked Questions How were Miromatrix Medical's earnings last quarter? Miromatrix Medical Inc. (NASDAQ:MIRO) released its quarterly earnings results on Monday, November, 15th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.13) by $0.12. The firm had revenue of $0.01 million for the quarter. Miromatrix Medical had a negative net margin of 2,861.17% and a negative trailing twelve-month return on equity of 120.49%. When did Miromatrix Medical IPO? Miromatrix Medical (MIRO) raised $32 million in an IPO on Thursday, June 24th 2021. The company issued 4,000,000 shares at a price of $7.00-$9.00 per share. Craig-Hallum Capital Group acted as the underwriter for the IPO. What other stocks do shareholders of Miromatrix Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Miromatrix Medical investors own include BitNile Metaverse (BNMV), Cognition Therapeutics (CGTX), Impel Pharmaceuticals (IMPL), Nyxoah (NYXH), Aceragen (ACGN), AcelRx Pharmaceuticals (ACRX) and Aldeyra Therapeutics (ALDX). Company Calendar Last Earnings11/15/2021Today10/16/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolNASDAQ:MIRO CIK1527096 Webwww.miromatrix.com Phone952-942-6000FaxN/AEmployees76Year Founded2009Profitability EPS (Trailing Twelve Months)($1.14) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$29.96 million Net Margins-2,861.17% Pretax Margin-2,861.17% Return on Equity-120.49% Return on Assets-90.70% Debt Debt-to-Equity Ratio0.02 Current Ratio3.46 Quick Ratio3.46 Sales & Book Value Annual Sales$958.03 thousand Price / Sales97.02 Cash FlowN/A Price / Cash FlowN/A Book Value$1.25 per share Price / Book2.71Miscellaneous Outstanding Shares27,419,000Free Float25,993,000Market Cap$92.95 million OptionableOptionable Beta0.01 Social Links The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:MIRO) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | SponsoredThe Final DisplacementA new documentary called The Final Displacement is stirring major controversy — and for good reason. It expose...Porter & Company | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Miromatrix Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Miromatrix Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
